A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 203 000 KRW 9.02% Market Closed
Market Cap: 11.2T KRW

Operating Margin
ABL Bio Inc

-23.3%
Current
-101%
Average
-3.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-23.3%
=
Operating Profit
-22.1B
/
Revenue
94.9B

Operating Margin Across Competitors

No Stocks Found

ABL Bio Inc
Glance View

ABL Bio, Inc. engages in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-12-19. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific antibodies (DICs), novel immune cell targeting antibodies (NICs), brain disease dual antibodies, antibody-drug conjugates (ADCs) , among others.

ABL Bio Inc Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-23.3%
=
Operating Profit
-22.1B
/
Revenue
94.9B
What is the Operating Margin of ABL Bio Inc?

Based on ABL Bio Inc's most recent financial statements, the company has Operating Margin of -23.3%.

Back to Top